{"product_id":"airwarelabs-pestle-analysis","title":"Airware Labs Corp. PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkip the Research. Get the Strategy.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic trends, social demands, technological advances, legal risks, and environmental pressures are shaping Airware Labs Corp.'s strategic outlook in our concise PESTLE snapshot; these actionable insights highlight potential risks and growth levers. Purchase the full PESTLE for a complete, editable breakdown and immediate recommendations to inform investments or strategy. Get it now and stay ahead.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare funding priorities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernment allocations to hospitals, EMS and public health—with US national health expenditures at about $4.5 trillion in 2022 and government payers covering roughly 46%—directly drive demand for airway and respiratory devices. Stimulus or austerity cycles shift procurement timing, so Airware Labs must tie product value to policy outcomes such as patient safety and surge capacity. Active engagement in policy forums can secure placement on funded equipment lists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory harmonization and divergence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eShifts between FDA, EU MDR (in force since 26 May 2021) and national frameworks alter market-access sequencing for Airware Labs, forcing prioritization of jurisdictions with clearer pathways. Divergent conformity requirements raise development costs and time-to-market, while strategic selection of reference markets and standards mapping reduces duplication and regulatory submissions. Post-market surveillance obligations—exemplified by MAUDE's \u0026gt;1,000,000 reports—heighten political scrutiny and ongoing safety compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePandemic preparedness agendas\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernments maintain stockpiling and readiness plans for respiratory crises—WHO has 194 member states coordinating preparedness frameworks since the COVID-19 pandemic. Inclusion in strategic reserves can stabilize baseline demand for diagnostics and PPE. Policy swings after crises have historically shifted funding priorities, leaving programs vulnerable. Airware Labs can position its solutions as critical infrastructure for rapid surge response and procurement pipelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic procurement and local-content policies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePublic procurement, roughly 12% of GDP globally and about €2 trillion annually in the EU, makes tender rules, buy-local incentives and price caps key to Airware Labs Corp competitiveness; domestic-sourcing pressure has pushed many suppliers to relocate or partner regionally to retain eligibility and margins.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTender rules: compliance boosts award odds\u003c\/li\u003e\n\u003cli\u003eBuy-local: improves scoring, may require regional assembly\u003c\/li\u003e\n\u003cli\u003ePrice caps: compress margins, favor scale\u003c\/li\u003e\n\u003cli\u003eTransparent value-for-money cases: critical for politically sensitive bids\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReimbursement politics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cppublic payers shape coverage in preventive and acute respiratory care medicare comprised about of us national health expenditures amplifying political influence. coding tariff updates month processes can unlock hospital home adoption. advocacy coalitions have accelerated inclusion timelines reimbursement delays or clawbacks create measurable policy risk to revenue visibility.\u003e\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic payer share: 36% (US NHE 2023)\u003c\/li\u003e\n\u003cli\u003eCoverage timeline: typically 6–12 months\u003c\/li\u003e\n\u003cli\u003eRisk: delays\/clawbacks reduce revenue predictability\u003c\/li\u003e\n\u003cli\u003eEnabler: coding\/tariff updates drive uptake\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ppublic\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment payers, procurement \u0026amp; regulatory divergence reshape medtech market access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernment health spend (US NHE ~4.5T in 2022; gov payers ~46%) and public procurement (~12% GDP; EU ~€2T\/yr) drive demand and favor buy-local\/tender compliance. Regulatory divergence (FDA, EU MDR) and MAUDE \u0026gt;1,000,000 reports raise market-access and surveillance costs. Inclusion in national stockpiles and Medicare\/Medicaid (36% of US NHE 2023) stabilizes revenue but faces political funding swings.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS health spend\u003c\/td\u003e\n\u003ctd\u003e$4.5T (2022)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGov payer share\u003c\/td\u003e\n\u003ctd\u003e46%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare\/Medicaid\u003c\/td\u003e\n\u003ctd\u003e36% (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic procurement\u003c\/td\u003e\n\u003ctd\u003e~12% GDP; EU €2T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMAUDE reports\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,000,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Airware Labs Corp across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—each section backed by current data and trends to identify actionable threats and opportunities for strategy and risk management.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondensed PESTLE summary of Airware Labs Corp. designed for quick meeting use—visually segmented by factor, editable for region-specific notes, and easily dropped into slides or shared to align teams on external risks and market positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital capital and operating budgets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMacroeconomic cycles tighten hospital capex and opex, and a 2024 Kaufman Hall survey found roughly 58% of hospitals curtailed capital projects, pushing buyers toward equipment that shows rapid payback.\u003c\/p\u003e\n\u003cp\u003eTight budgets favor devices demonstrating clear ROI via fewer complications and faster workflows — e.g., technologies that cut complication rates by ~15–25% or OR turnover by ~10–20% drive procurement decisions.\u003c\/p\u003e\n\u003cp\u003eSubscription or pay-per-use models gained traction in 2024 as 40–50% of systems sought OPEX-friendly procurement, so Airware Labs should quantify cost avoidance in clinical pathways and present modeled savings per 1,000 cases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInflation and input cost volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising polymer prices (≈+6% YoY in 2024) and continued premiums on sensors and specialty electronics compress Airware Labs Corp margins, while logistics and manufacturing wages—manufacturing pay rose roughly 4% in 2024—add further pressure to COGS. Dynamic pricing and dual-sourcing strategies have mitigated swings amid a 2024 global container rate average near $2,100. Design-to-cost programs preserve competitiveness and safety by trimming BOM costs without compromising certification.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency fluctuations on global sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRevenue billed in foreign currencies exposes Airware Labs to USD cost-base FX risk, notable as the US dollar held about 58% of global FX reserves in 2024 (IMF COFER), concentrating market impact on USD movements. Active hedging and natural offsets (local sourcing\/pricing) help stabilize gross margin. Regional pricing corridors manage affordability and volatility, and distributor contracts should include FX adjustment clauses where feasible.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayer mix in care settings\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePayer mix shifts—public vs private vs out-of-pocket—alter demand elasticity; US national health expenditures reached about 4.6 trillion USD in 2023 with public programs covering roughly half, increasing price sensitivity in publicly procured channels.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHome care market growth (~7% CAGR to 2028) diversifies revenue\u003c\/li\u003e\n\u003cli\u003eSKU\/pricing can be channel-tailored\u003c\/li\u003e\n\u003cli\u003eValue-based procurement rewards outcomes data for premium pricing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScale economies and manufacturing footprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVolume ramp lowers unit costs across disposables and reusable modules, improving gross margin leverage; McKinsey 2024 notes automation can cut assembly labor costs by up to 30%, boosting margin resilience. Nearshoring has shortened electronics lead times in 2023–24 by commonly 15–30%, reducing inventory risk. Contract manufacturing provides capacity flexibility during demand spikes without fixed-capex commitments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eScale economies: lower unit cost\u003c\/li\u003e\n\u003cli\u003eNearshoring: 15–30% lead-time reduction\u003c\/li\u003e\n\u003cli\u003eContract Mfg: flexible capacity\u003c\/li\u003e\n\u003cli\u003eAutomation: up to 30% labor cost cut (McKinsey 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment payers, procurement \u0026amp; regulatory divergence reshape medtech market access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDemand favors OPEX-friendly, fast-ROI devices as 58% of hospitals cut capex; subscription uptake ~40–50% boosts recurring revenue. Input costs (polymers +6% YoY, manufacturing wages +4%, container avg ~$2,100) compress margins; hedging, nearshoring and scale\/automation (up to 30% labor cut) mitigate risks. FX exposure large (USD ~58% reserves); payer mix and home-care growth (~7% CAGR to 2028) shape pricing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2023–24\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals curtailed capex\u003c\/td\u003e\n\u003ctd\u003e58%\u003c\/td\u003e\n\u003ctd\u003eProcurement shift to rapid-ROI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubscription adoption\u003c\/td\u003e\n\u003ctd\u003e40–50%\u003c\/td\u003e\n\u003ctd\u003eOPEX revenue growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolymer price change\u003c\/td\u003e\n\u003ctd\u003e+6% YoY\u003c\/td\u003e\n\u003ctd\u003eCOGS pressure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContainer rate\u003c\/td\u003e\n\u003ctd\u003e$2,100 avg\u003c\/td\u003e\n\u003ctd\u003eLogistics cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUSD share FX reserves\u003c\/td\u003e\n\u003ctd\u003e58%\u003c\/td\u003e\n\u003ctd\u003eFX risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHome care CAGR\u003c\/td\u003e\n\u003ctd\u003e~7% to 2028\u003c\/td\u003e\n\u003ctd\u003eMarket diversification\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAutomation labor cut\u003c\/td\u003e\n\u003ctd\u003eUp to 30%\u003c\/td\u003e\n\u003ctd\u003eMargin resilience\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNearshoring lead-time\u003c\/td\u003e\n\u003ctd\u003e15–30%\u003c\/td\u003e\n\u003ctd\u003eInventory risk down\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eAirware Labs Corp. PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe Airware Labs Corp. PESTLE Analysis examines political, economic, social, technological, legal and environmental factors affecting the company and offers actionable strategic insights and risk implications. It highlights regulatory risks, market drivers, tech trends and sustainability impacts. The preview shown here is the exact document you’ll receive after purchase—fully formatted and ready to use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162443985273,"sku":"airwarelabs-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/airwarelabs-pestle-analysis.png?v=1762700966","url":"https:\/\/portersfiveforce.com\/products\/airwarelabs-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}